Document is current
Any future updates will be listed below
-
Authors
Vikkurthi, Rajesh
Ansari, Asgar
Pai, Anupama R. https://orcid.org/0000-0003-0361-0237
Jha, Someshwar Nath
Sachan, Shilpa
Pandit, Suvechchha
Nikam, Bhushan
Kalia, Anurag
Jit, Bimal Prasad
Parray, Hilal Ahmad
Singh, Savita
Kshetrapal, Pallavi
Wadhwa, Nitya
Shrivastava, Tripti
Coshic, Poonam
Kumar, Suresh
Sharma, Pragya
Sharma, Nandini
Taneja, Juhi
Pandey, Anil K.
Sharma, Ashok
Thiruvengadam, Ramachandran https://orcid.org/0000-0002-9195-2730
Grifoni, Alba https://orcid.org/0000-0002-2209-5966
Weiskopf, Daniela
Sette, Alessandro https://orcid.org/0000-0001-7013-2250
Bhatnagar, Shinjini
Gupta, Nimesh https://orcid.org/0000-0001-9433-8448
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (75N9301900065, 75N93021C00016, 75N9301900065)
Department of Biotechnology, Ministry of Science and Technology (BT/PR40401/BIOBANK/03.2020, BT/PR30223/MED/2018)
DST | Science and Engineering Research Board (IPA/2020/000077)
- License Information
-
More Information
Article History
Received: 27 November 2021
Accepted: 24 May 2022
First Online: 9 June 2022
Competing interests
: N.G. and A.A. are listed as inventors on Indian patent application no. 202111003148 filed in 2021 (submitted by NII) that covers the use of ‘T-cell qualitative immunoassay’ for vaccine evaluation. A. Sette is consultant for GritstoneBio, FlowPharma, ArcturusTherapeutics, ImmunoScape, CellCarta, Avalia, Moderna, Fortress and Repertoire. LJI has filed USA patent protection for various aspects of T-cell epitope and vaccine design work. All other authors declare no competing interests.
Free to read: This content has been made available to all.
